AHA 2011 schedule: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 64: | Line 64: | ||
===9:00 AM=== | ===9:00 AM=== | ||
''9:00 AM - 9:30 AM'' | |||
*'''Interviewee:''' Dr. Peter Kowey | |||
*'''Topic:''' Double-blind placebo controlled dose ranging study of the efficacy and safety of celivarone 50, 100, or 300 mg od with amiodarone as calibrator for the prevention of ICD interventions or death (ALPHEE) | |||
*'''Embargo lift:''' 3:45 PM on Monday, November 14, 2011 | |||
===9:30 AM=== | ===9:30 AM=== | ||
| Line 97: | Line 100: | ||
*'''Interviewee:''' Dr. Gilles Montalescot | *'''Interviewee:''' Dr. Gilles Montalescot | ||
*'''Topic:''' AHA Wrap-Up in French | *'''Topic:''' AHA Wrap-Up in French | ||
==Tuesday November 15, 2011== | ==Tuesday November 15, 2011== | ||
Revision as of 13:32, 21 October 2011
Here is the page we will use to coordinate the TV events at AHA 2011. Open time slots are indicated below in red. Location for filming TBD.
Click on Date for Detailed Schedule
Sunday November 13, 2011
8:00 AM
OPEN TIME SLOT
8:30 AM
OPEN TIME SLOT
9:00 AM
OPEN TIME SLOT
9:30 AM
OPEN TIME SLOT
11:00 AM
OPEN TIME SLOT
11:30 AM
OPEN TIME SLOT
1:00 PM
OPEN TIME SLOT
1:30 PM
OPEN TIME SLOT
2:00 PM
OPEN TIME SLOT
2:30 PM
OPEN TIME SLOT
3:00 PM
OPEN TIME SLOT
3:30 PM
OPEN TIME SLOT
Monday November 14, 2011
8:00 AM
OPEN TIME SLOT
8:30 AM
OPEN TIME SLOT
9:00 AM
9:00 AM - 9:30 AM
- Interviewee: Dr. Peter Kowey
- Topic: Double-blind placebo controlled dose ranging study of the efficacy and safety of celivarone 50, 100, or 300 mg od with amiodarone as calibrator for the prevention of ICD interventions or death (ALPHEE)
- Embargo lift: 3:45 PM on Monday, November 14, 2011
9:30 AM
OPEN TIME SLOT
2:30 PM
2:30 PM - 3:00 PM
- Interviewee: Dr. John Spertus
- Topic: Testing an evidence-based, individualized informed-consent form to improve patients' experiences with PCI
- Embargo lift: 11:29 AM on Monday, November 14, 2011
3:00 PM
OPEN TIME SLOT
3:30 PM
OPEN TIME SLOT
4:00 PM
4:00 PM - 4:30 PM
- Interviewee: Dr. Samuel Goldhaber
- Topic: Extended anticoagulant prophylaxis in initially hospitalized medically ill patients: Results of the ADOPT (Apixaban Dosing to Optimize Protection from Thrombosis) trial
- Embargo lift: 4:29 PM on Sunday, November 13, 2011
4:30 PM
OPEN TIME SLOT
5:00 PM
OPEN TIME SLOT
5:30 PM
5:30 PM - 6:00 PM
- Interviewee: Dr. Gilles Montalescot
- Topic: AHA Wrap-Up in French
Tuesday November 15, 2011
8:00 AM
8:00 AM - 8:30 AM
- Interviewee: Dr. Paul Armstrong
- Topic: AHA Wrap-Up from a Canadian Perspective
8:30 AM
OPEN TIME SLOT
10:30 AM
OPEN TIME SLOT
11:00 AM
OPEN TIME SLOT
11:30 AM
OPEN TIME SLOT
1:30 PM
OPEN TIME SLOT
2:00 PM
OPEN TIME SLOT
2:30 PM
2:30 PM - 3:00 PM
- Interviewee: Dr. William Boden
- Topic: Extended-release niacin does not reduce clinical events in patients with established cardiovascular disease whose LDL cholesterol is optimally controlled with statin therapy: Results from the AIM-HIGH trial
- Embargo lift: 11:51 AM on Tuesday, November 15, 2011
3:00 PM
OPEN TIME SLOT
3:30 PM
OPEN TIME SLOT
4:00 PM
OPEN TIME SLOT
4:30 PM
OPEN TIME SLOT
5:00 PM
OPEN TIME SLOT
5:30 PM
OPEN TIME SLOT